Chemoinformaics analysis of 2,6-Dimethylnaphthalene
| Molecular Weight | 156.228 | nRot | 0 |
| Heavy Atom Molecular Weight | 144.132 | nRig | 11 |
| Exact Molecular Weight | 156.094 | nRing | 2 |
| Solubility: LogS | -4.92 | nHRing | 0 |
| Solubility: LogP | 4.299 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 2 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 11 |
| nHA | 0 | APOL | 28.0415 |
| nHD | 0 | BPOL | 12.0385 |
| QED | 0.548 |
| Synth | 1.414 |
| Natural Product Likeliness | -0.393 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.095 |
| Pgp-sub | 0.017 |
| HIA | 0.003 |
| CACO-2 | -4.43 |
| MDCK | 0.0000171 |
| BBB | 0.827 |
| PPB | 0.963817 |
| VDSS | 0.874 |
| FU | 0.0368902 |
| CYP1A2-inh | 0.947 |
| CYP1A2-sub | 0.917 |
| CYP2c19-inh | 0.683 |
| CYP2c19-sub | 0.559 |
| CYP2c9-inh | 0.421 |
| CYP2c9-sub | 0.751 |
| CYP2d6-inh | 0.594 |
| CYP2d6-sub | 0.92 |
| CYP3a4-inh | 0.26 |
| CYP3a4-sub | 0.466 |
| CL | 10.436 |
| T12 | 0.328 |
| hERG | 0.08 |
| Ames | 0.541 |
| ROA | 0.055 |
| SkinSen | 0.724 |
| Carcinogencity | 0.807 |
| EI | 0.994 |
| Respiratory | 0.036 |
| NR-Aromatase | 0.011 |
| Antiviral | No |
| Prediction | 0.684524 |